| 000 | 02436 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250517010824.0 | ||
| 264 | 0 | _c20160606 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2014.12.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoerensen, Anne V | |
| 245 | 0 | 0 |
_aHealth economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2. _h[electronic resource] |
| 260 |
_bEuropean urology _cSep 2015 |
||
| 300 |
_a516-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmbulatory Care _xeconomics |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xeconomics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aBevacizumab _xeconomics |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDenmark |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aEfficiency |
| 650 | 0 | 4 |
_aEmployment _xeconomics |
| 650 | 0 | 4 |
_aEverolimus _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xeconomics |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 |
_aHospitalization _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xeconomics |
| 650 | 0 | 4 |
_aIndoles _xeconomics |
| 650 | 0 | 4 |
_aInterferon-alpha _xeconomics |
| 650 | 0 | 4 |
_aInterleukin-2 _xeconomics |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xdrug therapy |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xeconomics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xeconomics |
| 650 | 0 | 4 |
_aPyrroles _xeconomics |
| 650 | 0 | 4 |
_aRadiography _xeconomics |
| 650 | 0 | 4 |
_aRadiotherapy _xeconomics |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _aDonskov, Frede | |
| 700 | 1 | _aKjellberg, Jakob | |
| 700 | 1 | _aIbsen, Rikke | |
| 700 | 1 | _aHermann, Gregers G | |
| 700 | 1 | _aJensen, Niels V | |
| 700 | 1 | _aFode, Kirsten | |
| 700 | 1 | _aGeertsen, Poul F | |
| 773 | 0 |
_tEuropean urology _gvol. 68 _gno. 3 _gp. 516-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2014.12.017 _zAvailable from publisher's website |
| 999 |
_c24481508 _d24481508 |
||